Richard Ramanius

Richard Ramanius, CFA, is an equity analyst at Redeye AB since August 2021, specializing in biotech with a focus on oncology and currently covering ten companies. Prior experience includes an equity analyst role at Carlsquare from January 2020 to August 2021, initially covering over ten life science companies and later diversifying into various sectors. Richard held managerial positions in sales and export engineering across several companies from 2012 to 2017, including Gewiss and Isoclima S.p.A., with responsibilities in Scandinavia and Northern Europe. Richard's educational background features a Bachelor of Science in Engineering Physics from KTH Royal Institute of Technology and a Master of Philosophy in Roman History from the University of Oxford, alongside degrees in Classical Archaeology, Ancient History, and Theoretical Philosophy from Stockholm University and Università per Stranieri di Perugia.